Vivanza Biosciences P/B Ratio
Vivanza Biosciences (VIVANZA) P/B ratio is 1.62 (Moderate), book value per share ₹10.00 vs Healthcare average P/B of -0.33 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see Vivanza Biosciences share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
VIVANZA P/B Ratio — Valuation Insights & Book Value Analysis
Vivanza Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 1.62 (Moderate). Compare with Vivanza Biosciences value estimation to assess whether the stock is under or overvalued.
- Current PB is 270.3% above historical average
- Trading at premium to sector average PB of -0.33
Vivanza Biosciences P/B Ratio Historical Trend
VIVANZA annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Vivanza Biosciences yearly highs lows for the annual high/low range and current price position.
VIVANZA Historical P/B Ratio — Book Value Per Share & Year-End Price
Vivanza Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.18 | ₹10.0 | ₹1.76 | ₹4 | Low |
| 2025 | 0.22 | ₹10.0 | ₹2.20 | ₹4 | Low |
| 2024 | 0.27 | ₹12.5 | ₹3.42 | ₹5 | Low |
| 2023 | 1.08 | ₹10.0 | ₹10.77 | ₹4 | Moderate |
VIVANZA vs Healthcare Peers — P/B Ratio Comparison
Vivanza Biosciences P/B 1.62 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |